Background/Objectives: Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Early and accurate characterization of suspicious mammographic microcalcifications is essential for improving diagnostic decision-making and reducing unnecessary invasive procedures. Microcalcifications classified as BI-RADS 4 and BI-RADS 5 are clinically important radiological findings; however, differentiating benign from malignant lesions remains challenging because of overlapping morphological and distribution patterns. This study aimed to develop a structured feature-based machine learning model for predicting the pathological diagnosis of breast microcalcifications by integrating mammographic descriptors, patient age, and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) contrast enhancement findings. Methods: The dataset included 53 biopsy-confirmed cases and consisted of clinical and radiological variables, including patient age, calcification morphology, calcification size, distribution pattern, DCE-MRI contrast enhancement status, and histopathological outcome. Several conventional machine learning algorithms were evaluated, including Logistic Regression, Support Vector Machine with radial basis function kernel, K-Nearest Neighbors, Decision Tree, Random Forest, Extra Trees, Gradient Boosting, AdaBoost, and CatBoost. Hyperparameter optimization was performed using grid search with five-fold cross-validation. Model performance was assessed using accuracy, precision, recall, F1-score, ROC-AUC, and log loss. Results: Logistic Regression achieved the highest overall performance, with an accuracy of 0.909 and an F1-score of 0.889, while AdaBoost achieved a recall of 1.000 in the internal evaluation. However, given the limited sample size and lack of external validation, these findings should be interpreted as preliminary. Conclusions: The results suggest that structured radiological descriptors combined with DCE-MRI enhancement information may support malignancy risk stratification of BI-RADS 4–5 microcalcifications, although larger multicenter studies are required before clinical implementation.
Unal et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: